January 2, 2024 · Form 4 insider transaction
Mathew Aby J. sold 697 shares of BioLife Solutions, Inc. at $16.75 per share, a transaction worth $11.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.